# A Clinical Investigation to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease

Study · id `cardio:ct-nct05206084` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05206084](<https://clinicaltrials.gov/study/NCT05206084>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05206084

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 518 participants.

## Technical summary

Registry record NCT05206084. Randomized; single masking; primary purpose treatment. Start 2022-03-10 (actual); primary completion 2024-12-29 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 518 participants (enrolled count; ClinicalTrials.gov record NCT05206084, source copy `cardio:ctgov-nct05206084-2025-12-10`, retrieved 2026-10-26)
- Started: 2022-03-10 (actual) (ClinicalTrials.gov record NCT05206084, source copy `cardio:ctgov-nct05206084-2025-12-10`, retrieved 2026-10-26)
- Primary completion: 2024-12-29 (actual) (ClinicalTrials.gov record NCT05206084, source copy `cardio:ctgov-nct05206084-2025-12-10`, retrieved 2026-10-26)
- Completion: 2028-01 (anticipated) (ClinicalTrials.gov record NCT05206084, source copy `cardio:ctgov-nct05206084-2025-12-10`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05206084, source copy `cardio:ctgov-nct05206084-2025-12-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05206084-2025-12-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Clinical Investigation to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease
- Acronym: IRONMAN-II
- Condition: Coronary Artery Disease
- Intervention (Device): Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System (IBS)
- Intervention (Device): Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System
- Lead sponsor: Biotyx Medical (Shenzhen) Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Biotyx Medical (Shenzhen) Co., Ltd. (`cardio:org-biotyx-medical-shenzhen-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Sirolimus-Eluting Iron Bioresorbable Scaffolds vs Everolimus-Eluting Stents for Percutaneous Coronary Intervention: A Randomized Trial (IRONMAN II) (`cardio:pubmed-41670556`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 152b5db96c5d3aacb4da0cd86183bcb01fac0cf7e4bac01719c6b517bf43ed8b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
